Atlas Trials

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Clinical trial NCT02958865 · COMPLETED

Trial details

NCT number
NCT02958865
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2017-02-03
Primary completion
2021-05-10
Enrollment
319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.